Loading clinical trials...
Loading clinical trials...
The primary objective of this study is to evaluate the pharmacokinetics of entospletinib (ENTO) and/or its metabolites (if applicable) in participants with impaired hepatic function (stratified by smo...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Gilead Sciences
NCT06868524 · Cancer Survivor, Cancer, and more
NCT06815120 · Catheter Blockage, Oncology, and more
NCT06237816 · Cancer, Oncology
NCT06856902 · Cardiovascular Diseases, Endocrinology, and more
NCT06443138 · Geriatric Oncology
Clinical Pharmacology of Miami, Inc. (CPMI)
Miami, Florida
Orlando Clinical Research Center
Orlando, Florida
DaVita Clinical Research
Minneapolis, Minnesota
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions